Applied Biosystems Obtains Injunctions In Germany Against Bio-Rad And MJ Research
Companies enjoined from selling certain thermal cyclers; similar injunction previously issued against Bio-Rad in Japan
Foster City. Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced that the German District Court in Düsseldorf, Germany, has issued injunctions against Bio-Rad Laboratories, Inc. , MJ Research, Inc., and Biozym, MJ Research's distributor in Germany. The injunctions proscribe the manufacture and sale of real-time thermal cyclers capable of performing real-time PCR (polymerase chain reaction) methods. The Court found that the defendants infringe the German national patent corresponding to European Patent No. 872562, issued to Applera in September 2002.
In April 2003, a similar injunction was obtained against Bio-Rad in Japan based on a corresponding Japanese patent.
"The foundational real-time PCR instrument patents issued to Applera in Europe and Japan are valuable parts of our intellectual property estate and reflect our continuing investment in innovation in this important area of our technology," said Michael W. Hunkapiller, Ph.D., President of Applied Biosystems. "We are pleased that the courts in Germany and Japan have recognized the enforceability of these patents."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
